Finally—cardiovascular disease (CV) is becoming more manageable. However, as evidence-based therapies emerge to reduce CV events, including mortality, selecting the appropriate therapy for patients is still a challenge. Health care providers can reference the 2017 American College of Cardiology and National Lipid Association evidence-based, patient-centered recommendations for management of dyslipidemia. Learn how to lower atherosclerotic cardiovascular disease (ASCVD), the role of nonstatin therapies in ASCVD risk reduction, and how to identify patients who may be appropriate for treatment.
At the completion of this application-based activity, participants will be able to:
- Discuss recent evidence-based updates in atherosclerotic cardiovascular disease risk reduction and cholesterol management.
- Recommend treatment strategies for patients with hyperlipidemia who complain of statin-associated muscle symptoms.
- Discuss the evidence evaluating the efficacy and safety of nonstatin therapies in patients with dyslipidemia, including the impact on long-term cardiovascular outcomes.
- Describe recommendations for appropriate use of nonstatin therapies based on recommendations from authoritative national organizations.
- List investigational drug therapies for treatment of dyslipidemia.
- Formulate patient-centered treatment plans for patients with hyperlipidemia, beyond statin therapy.
Activity type: Application-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 2.0 contact hour of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-083-H01-P.
To obtain credit for completing Your Annual Cholesterol Management Update: Reducing ASCVD Risk, watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: March 25, 2019
Expiration date: March 25, 2022
Your Annual Cholesterol Management Update: Reducing ASCVD Risk is an archived, online educational activity for pharmacists developed by the American Pharmacists Association.
Joseph Saseen, PharmD, BCPS, BCACP; Janelle Ruisinger, PharmD, FAPhA; and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
There is no fee associated with this member only activity as part of the 2019 Home Study on Demand package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements.